Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2370371
Max Phase: Preclinical
Molecular Formula: C43H65N13O10S
Molecular Weight: 956.14
Molecule Type: Protein
Associated Items:
ID: ALA2370371
Max Phase: Preclinical
Molecular Formula: C43H65N13O10S
Molecular Weight: 956.14
Molecule Type: Protein
Associated Items:
Canonical SMILES: CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CSC(C)(C)[C@@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)NC(C)(C)C(=O)O
Standard InChI: InChI=1S/C43H65N13O10S/c1-24(54(7)37(62)28(50-32(58)21-46-6)10-8-16-48-41(44)45)34(59)51-29(18-25-12-14-27(57)15-13-25)39(64)56-23-67-43(4,5)33(56)36(61)52-30(19-26-20-47-22-49-26)38(63)55-17-9-11-31(55)35(60)53-42(2,3)40(65)66/h12-15,20,22,24,28-31,33,46,57H,8-11,16-19,21,23H2,1-7H3,(H,47,49)(H,50,58)(H,51,59)(H,52,61)(H,53,60)(H,65,66)(H4,44,45,48)/t24-,28-,29-,30-,31-,33-/m0/s1
Standard InChI Key: SFYHHHFRPLWRDT-PMJBBQITSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 956.14 | Molecular Weight (Monoisotopic): 955.4698 | AlogP: -1.87 | #Rotatable Bonds: 22 |
Polar Surface Area: 339.97 | Molecular Species: ZWITTERION | HBA: 13 | HBD: 10 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.73 | CX Basic pKa: 10.85 | CX LogP: -4.69 | CX LogD: -5.61 |
Aromatic Rings: 2 | Heavy Atoms: 67 | QED Weighted: 0.04 | Np Likeness Score: 0.19 |
1. Samanen J, Cash T, Narindray D, Brandeis E, Adams W, Weideman H, Yellin T, Regoli D.. (1991) An investigation of angiotensin II agonist and antagonist analogues with 5,5-dimethylthiazolidine-4-carboxylic acid and other constrained amino acids., 34 (10): [PMID:1920354] [10.1021/jm00114a012] |
Source(1):